Parametric Portfolio Associates’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$17.8M Buy
215,042
+90,520
+73% +$6.67M 0.01% 1026
2021
Q4
$9.35M Buy
124,522
+36,311
+41% +$3.64M ﹤0.01% 1438
2021
Q3
$10.2M Sell
88,211
-14,058
-14% -$2.13M 0.01% 1339
2021
Q2
$22.7M Buy
102,269
+33,950
+50% +$6.6M 0.01% 896
2021
Q1
$9.03M Buy
68,319
+14,727
+27% +$2.33M 0.01% 1753
2020
Q4
$9.27M Sell
53,592
-945
-2% -$129K 0.01% 1628
2020
Q3
$6.07M Sell
54,537
-4,009
-7% -$321K ﹤0.01% 1745
2020
Q2
$3.47M Sell
58,546
-11,346
-16% -$746K ﹤0.01% 2125
2020
Q1
$4.71M Sell
69,892
-2,843
-4% -$225K ﹤0.01% 1774
2019
Q4
$6.13M Sell
72,735
-15,628
-18% -$1.26M ﹤0.01% 1896
2019
Q3
$6.61M Buy
88,363
+24,929
+39% +$1.99M 0.01% 1802
2019
Q2
$4.01M Sell
63,434
-5,399
-8% -$274K ﹤0.01% 2167
2019
Q1
$3.32M Sell
68,833
-5,583
-8% -$269K ﹤0.01% 2289
2018
Q4
$2.49M Sell
74,416
-16,992
-19% -$621K ﹤0.01% 2434
2018
Q3
$4.79M Sell
91,408
-22,864
-20% -$910K ﹤0.01% 2052
2018
Q2
$3.58M Buy
114,272
+47,886
+72% +$1.33M ﹤0.01% 2236
2018
Q1
$1.45M Sell
66,386
-33,542
-34% -$721K ﹤0.01% 2803
2017
Q4
$2.02M Buy
99,928
+58,074
+139% +$1.12M ﹤0.01% 2598
2017
Q3
$831K Buy
41,854
+24,165
+137% +$475K ﹤0.01% 3139
2017
Q2
$306K Buy
+17,689
New +$228K ﹤0.01% 3624

Other funds holding NVCR